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LETTERS TO THE EDITORSUBCOSTAL APPROACH FOR
REPLACEMENT OF FAILING
CIRCULATORY PUMPS
To the Editor:
The technique presented by Rogers
and colleagues1 is easy to perform and
very useful. In our institution, we use
a similar technique with some modifi-
cations to replace failing circulatory
pumps.
In the case of cable damage of the
HeartMate II or HeartWare HVAD
pump and a hemodynamically stable
patient, we first prepare the femoral
vessels and the cardiopulmonary
bypass is left on standby. After dissec-
tion of the pump as described by
Rogers and colleagues,1 the new
pump is brought into the operating
field and the cable is tunneled through
the skin and connected to the control-
ler ready for use. One hundred fifty in-
ternational units of heparin per
kilogram of body weight are adminis-
tered intravenously. In the case of
HeartMate II, the screws are loosened
and then disconnected. The assistant
secures both the openings with
thumbs and the surgeon first connects
the new pump to the outflow graft,
flushes the pump, and tightens the first
screw. Alternatively, the openings
may be temporarily closed by intro-
ducing and blocking a Foley catheter.
The next step is to connect the pump
to the inflow graft under continuous
flushing and then tighten the second
screw. In patients with the HeartWare
HVAD, the outflow graft is cross-
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1272 The Journal of Thoracic andthe fixation ring is closed temporarily
with a specially designed titanium
plug (Fittkau Metallbau GmbH, Ber-
lin, Germany). In the next step the out-
flow graft is unscrewed and detached
from the damaged pump, connected
to the new pump, and tightened. The
pump is introduced into the fixation
ring under continuous flushing (after
removal of the titanium plug). Transe-
sophageal echocardiography continu-
ously monitors the cavity of the left
ventricle and ascending aorta for air.
This modification avoids the use of
cardiopulmonary bypass and sim-
plifies the procedure. For patients in
unstable condition, however, cardio-
pulmonary bypass should be estab-
lished for safety reasons.
In 1 case of HeartAssist5 and 1 of
Terumo DuraHeart thrombosis, we
used cardiopulmonary bypass through
the femoral vessels and exchanged the
pump for a HeartWare HVAD with
a similar approach. In 1 case of repeat
thrombosis in a second HeartMate II
pump, a HeartWare HVAD was simi-
larly implanted. In these cases, the in-
flow cannula was dissected and
removed with the fixation ring. Next,
the fixation ring of the HeartWare
HVAD was sewn to the apex on the al-
ready existing opening and the outflow
graft (10mm)was sewn to the proximal
part of the outflow graft of the
HeartAssist5 or Terumo DuraHeart
(12 mm) or HeartMate II (16 mm)
end to end from the same approach.
From our experience, we can
recommend the subcostal approach
for pump exchange in the case of
thrombosis or irreparable cable dam-
age or pump removal after myocardial
recovery.
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DIAGNOSING NODAL
METASTASES: A CONCERN
To the Editor:
Carcinoma of the lungs remains
a highly lethal lesion despite many
interventions and advanced research
during the past quarter of a century.
Staging of these patients to avoid
unnecessary thoracotomy and surgical
resection has become a strong consid-
eration in patients with mediastinal
concerns. The article ‘‘Utility of
Endobronchial Ultrasound-Guided
Mediastinal Lymph Node Biopsy
in Patients With Non–Small Cell
Lung Cancer’’ presents a comparison
between 2 biopsy modalities: en-
dobronchial ultrasound-guided trans-
bronchial needle aspiration
(EBUS-TBNA) and mediastinoscopy.1
The accuracyof theEBUSprocedure in
the clinical setting has been well pre-
sented and demonstrates a potential
method for reducing morbidity and po-
tential major complications of the me-
diastinoscopic approach.
EBUS-TBNAdemonstratedahighly
accurate staging of the 73 patients re-
viewed. In their discussion, Lee and
colleagues1 mentioned that mediasti-
noscopy would have changed the tu-
mor stage and treatment planning in
only 2 of the 73 patients (2.7%).
They discussed the sensitivity, speci-
ficity, and negative predictive value as
well as the accuracy of the procedure.
Of note, they mentioned that the pa-
tients with positive mediastinal biopsy
findings were not surgical candidates.
Because of an advanced disease stage
(IIIB) or unresectable disease, the pa-
tients did not undergo additional tissue
acquisition from the mediastinum.
They further mentioned that patients
with positive biopsy results for meta-
static carcinoma did not undergo
mediastinoscopy.12
Letters to the EditorAwordof caution, however, is exem-
plified by one of our patients who had
proven adenocarcinoma of the right
lung and a positron emission tomo-
graphic scan that demonstrated
bilateral hilar and mediastinal uptake
suggestive of nodal metastasis. EBUS
biopsy of both the right and left paratra-
cheal and hilar areas demonstrated ma-
lignant cells when a biopsy was
acquired from the right side. On the ba-
sis of this finding, the patient was rec-
ommended not to have additional
interventional therapy, but rather to
have a regimen of chemotherapy and
radiotherapy. When we were consulted
for a second opinion. On review of her
studies, it was our feeling that she did
not have strong evidence of metastatic
disease. Surgical intervention with up-
per lobectomy and removal of 18 hilar
and mediastinal lymph nodes revealed
no positive nodal metastasis on micro-
scopic pathologic review.
On retrospective review of the orig-
inal EBUS study, there were both ma-
lignant cells and lymphoid cells
within the specimen. Our feeling, ret-
rospectively, was that a false-positive
report suggesting metastatic disease
resulted from the needle passing
through the node and into the lung,
thus obtaining pulmonary carcinoma
cells compared with nodal carcinoma
cells. This may lead to a potential mis-
diagnosis and misstaging, resulting
from a false-positive result of meta-
static carcinoma to the lymph nodes,
and a nonoperative or different thera-
peutic recommendation.
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LEFT MAIN STEM DISEASE
To the Editor:
We read with great interest the arti-
cle by Murzi and colleagues1 regard-
ing the best surgical management in
coronary artery disease patients with
left main stem disease undergoing sur-
gical revascularization. The authors
present a high quality observational
study comparing off-pump coronary
artery bypass grafting (CABG) with
on-pump CABG, in a large cohort of
consecutive patients with left main
stem disease over a period of 15 years.
Actually, 2 randomized studies had
already addressed this question: the
Veterans Affairs Randomized On/Off
Bypass (ROOBY) trial2 and the
CABG Off or On Pump Revasculari-
zation Study (CORONARY) trial.3
The CORONARY trial3 is the larg-
est multinational, prospective, ran-
domized trial to date, involving
4,752 patients, conducted in 19 coun-
tries at 79 centers. More than 20%
of enrolled patients showed signifi-
cant left main stem disease. At 30
days after randomization, there was
no significant difference between
off-pump and on-pump CABG
with respect to the rate of death,
nonfatal myocardial infarction, non-
fatal stroke, or renal failure requiring
dialysis. Subgroup analyses showed
that there was no significant differ-
ence concerning the coprimary out-
come in patients (n ¼ 1001) with
left main stem disease at 1 month af-
ter randomization (off-pump n ¼ 514
patients, on-pump n ¼ 487; hazard
ratio, 0.80; 95% confidence interval,
0.55-1.16; P ¼ .24). The sure-to-
be-forthcoming midterm and long-
term primary outcomes results will
influence the interpretation of the
CORONARY trial.
The ROOBY trial,2 which involved
2,203 male patients in 18 Veterans
Affairs medical centers demonstrated
no advantage for off-pump CABG
either at 30 days or at 1 year after
surgery. There was no significantof Thoracic and Cardiovascular Surgerdifference between the 2 cohorts
concerning the primary short-term
(ie, before discharge or within 30
days after surgery) composite out-
come of death or postoperative major
morbidity (ie, reoperation, new me-
chanical support, cardiac arrest,
coma, stroke, or renal failure requir-
ing dialysis). However, at 1-year
follow-up, patients in the beating-
heart technique group experienced
worse composite outcomes (ie, death
from any cause, repeat revasculariza-
tion procedure, or nonfatal myocar-
dial infarction) than did patients in
the on-pump group. The rate of graft
patency was significantly lower in the
off-pump group than in the on-pump
group (82.6% vs 87.8%; P < .01)
at 1 year and this accounted for
most of the difference in late com-
posite outcomes between the 2
groups. Notably, Shroyer et al2 state
that their ROOBY trial conclusions
can be generalized to subgroups of
high risk candidates, among them pa-
tients with left stem main disease.
We have only 1 question for Murzi
and colleagues1 regarding their surgi-
cal management in the off-pump
group: Might the 0% stroke result
found in the off-pump CABG group
have been the result of using total arte-
rial revascularization and aortic ‘‘no-
touch’’ techniques? Both of those
methods decrease significantly the
incidence of stroke after CABG,
particularly in patients with aortic
atherosclerosis.
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